scholarly journals Long-term interleukin-33 treatment delays disease onset and alleviates astrocytic activation in a transgenic mouse model of amyotrophic lateral sclerosis

IBRO Reports ◽  
2019 ◽  
Vol 6 ◽  
pp. 74-86 ◽  
Author(s):  
Paula Korhonen ◽  
Eveliina Pollari ◽  
Katja M. Kanninen ◽  
Ekaterina Savchenko ◽  
Šárka Lehtonen ◽  
...  
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Disease Onset ◽  
Transgenic Mouse Model ◽  
Treatment Delays ◽  
Interleukin 33 ◽  
Lateral Sclerosis

The antioxidantN-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis

1998 ◽  
Vol 44 (2) ◽  
pp. 293-293 ◽  
Author(s):  
Dick Jaarsma ◽  
Henk-Jan Guchelaar ◽  
Elize Haasdijk ◽  
J. M. B. Vianney de Jong ◽  
Jan C. Holstege
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Disease Onset ◽  
Transgenic Mouse Model ◽  
Delay Disease Onset ◽  
Lateral Sclerosis

scholarly journals N-acetyl-l-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model

2015 ◽  
Vol 80 ◽  
pp. 93-103 ◽  
Author(s):  
Wei Li ◽  
Anastasios Fotinos ◽  
Qiaofeng Wu ◽  
Yanchun Chen ◽  
Yongjin Zhu ◽  
...  
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Mouse Model ◽  
Transgenic Mouse ◽  
Disease Onset ◽  
Transgenic Mouse Model ◽  
Lateral Sclerosis
Sign in / Sign up

Export Citation Format

Share Document